{"id":"W2315722463","doi":"10.1093/annonc/mdw147","title":"Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Kyowa Hakko Kirin; National Comprehensive Cancer Network; Sanofi; PharmaMar; AstraZeneca; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Paclitaxel; Placebo; Oncology; Ovarian cancer; Gynecology; Internal medicine; Cancer; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003841053,0.0002339651,0.0009236246,0.0001574633,0.0001081228,0.0002799741,0.0002082535,0.0003332229,0.001625641],"category_scores_gemma":[0.0009063671,0.0001540489,0.0007566257,0.0001809696,0.0001900692,0.0002558456,0.0001820671,0.0006799938,0.0001205924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002797742,"about_ca_system_score_gemma":0.0002907404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001022152,"about_ca_topic_score_gemma":0.002025829,"domain_scores_codex":[0.9998689,0.00005771221,0.00001051633,0.0000200828,0.00001091606,0.00003180782],"domain_scores_gemma":[0.9998021,0.00006612593,0.0000564776,0.000009037967,0.000008744473,0.00005761871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7856821,0.005146178,0.06919248,0.0007900873,0.0028008,0.0002658592,0.0002246565,0.001091955,0.01097383,0.0001110335,0.001090207,0.1226307],"study_design_scores_gemma":[0.1612678,0.3360509,0.4865225,0.0001970159,0.005730236,0.0005848398,0.0005225882,0.002815034,0.003020186,0.0003390873,0.002878677,0.00007109385],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975256,0.001765517,0.0000246381,0.0001224142,0.00004678595,0.00002390477,0.000110779,0.000005944123,0.0003744634],"genre_scores_gemma":[0.9987183,0.000629834,0.00004550123,0.00008912873,0.00003337291,0.00003338431,0.0001507415,0.000001368006,0.0002985235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001625641,"threshold_uncertainty_score":0.005438268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1373859497395359,"score_gpt":0.4197746250834984,"score_spread":0.2823886753439624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}